C. Simonton

发表

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.

Peter L Duffy, G. Stone, T. Henry, 2017, JACC. Cardiovascular interventions.

Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial.

G. Stone, D. Kereiakes, D. Cutlip, 2013, American heart journal.

Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy

W. O’Neill, J. Moses, M. Leon, 2004, Circulation.

Feasibility of 320-row multi-detector computed tomography angiography to assess bioabsorbable everolimus-eluting vascular scaffolds

P. Serruys, S. Saito, K. Tanabe, 2016, Cardiovascular Intervention and Therapeutics.

Myocardial protection during coronary angioplasty with an autoperfusion balloon catheter in humans.

C. Simonton, P. Quigley, R. Stack, 1988, Circulation.

Outcomes with drug‐eluting stents versus bare metal stents in acute ST‐elevation myocardial infarction: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group

B. Brodie, T. Stuckey, J. Hermiller, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Rotational and directional coronary atherectomy

R. Bersin, C. Simonton, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.

Sunil V. Rao, Jonathan H Seltzer, I. Piña, 2020, American heart journal.

The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention

C. Simonton, D. Morris, Jason R. Wollmuth, 2020 .

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

S. Pocock, P. Serruys, G. Stone, 2016, The New England journal of medicine.

Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.

P. Fitzgerald, P. Serruys, G. Stone, 2020, JACC. Cardiovascular interventions.

Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease

S. Pocock, P. Serruys, G. Stone, 2020 .

Mortality After Repeat Revascularization Following PCI or Coronary Artery Bypass Grafting for Left Main Disease: The EXCEL Trial.

S. Pocock, P. Serruys, G. Stone, 2020, JACC. Cardiovascular interventions.

Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial

P. Serruys, G. Stone, D. Kandzari, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?

D. Kereiakes, J. Hermiller, C. Simonton, 2017, Coronary artery disease.

Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials

P. Serruys, G. Stone, M. Krucoff, 2015, Circulation. Cardiovascular interventions.

Long-Term Clinical Outcomes After Everolimus- and Sirolimus-Eluting Coronary Stent Implantation: Final 3-Year Follow-Up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial

T. Akasaka, K. Tanabe, Takeshi Kimura, 2014, Circulation. Cardiovascular interventions.

Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty.

C. O'connor, D. Mark, C. Simonton, 1988, Journal of the American College of Cardiology.

Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.

P. Serruys, G. Stone, M. Morice, 2018, JACC. Cardiovascular interventions.

New Inotropic Agents

C. Simonton, K. Chatterjee, 1985 .

Sex disparities in acute myocardial infarction care and outcomes

A. Baumbach, A. Lansky, K. Kozuma, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

S. Pocock, P. Serruys, G. Stone, 2019, The New England journal of medicine.

Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.

S. Pocock, P. Serruys, G. Stone, 2018, Journal of the American College of Cardiology.

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial.

Hiroki Shiomi, Satoshi Yasuda, Yoshinobu Onuma, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial).

G. Stone, A. Lansky, V. Ng, 2011, The American journal of cardiology.

The StarClose® vascular closure system: Interventional results from the CLIP study

C. O'shaughnessy, J. Hermiller, C. Simonton, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS).

P. Fitzgerald, P. Yock, R. Bersin, 1998, Circulation.

‘Optimal’ Directional Coronary Atherectomy

P. Fitzgerald, P. Yock, R. Bersin, 1998 .

Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.

S. Pocock, P. Serruys, G. Stone, 2020, Journal of the American College of Cardiology.

Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.

P. Serruys, G. Stone, M. Leon, 2019, European heart journal.

The ventilatory threshold: quantitative analysis of reproducibility and relation to arterial lactate concentration in normal subjects and in patients with chronic congestive heart failure.

M. Higginbotham, F. Cobb, C. Simonton, 1988, The American journal of cardiology.

Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.

D. Kereiakes, C. Simonton, G. Modin, 1987, Chest.

Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.

Sunil V. Rao, J. Moses, B. Strauss, 2009, JACC: Cardiovascular Interventions.

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

R. Cody, C. Simonton, K. Chatterjee, 1985, Journal of the American College of Cardiology.

Acute dose range study of milrinone in congestive heart failure.

R. Cody, C. Simonton, K. Chatterjee, 1985, The American journal of cardiology.

therapy of coronary angioplasty and high-dose intravenous streptokinase Coronary perfusion during acute myocardial infarction with a combined

E. B. Carlson, C. Simonton, V. Behar, 2005 .

Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humans

J. Palmaz, J. Granada, Juan A. Delgado, 2017, Open Heart.

Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).

G. Stone, D. Cohen, M. Reynolds, 2012, The American journal of cardiology.

CRUISE: can routine intravascular ultrasound influence stent expansion? Analysis of outcomes

P. Fitzgerald, P. Yock, M. Leon, 1998 .

The risk for systemic embolization associated with percutaneous balloon valvuloplasty in adults. A prospective comprehensive evaluation.

C. Simonton, T. Bashore, V. Behar, 1988, Annals of internal medicine.

Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

P. Serruys, G. Stone, Z. Ali, 2019, JAMA cardiology.

Current practices of Asia-Pacific cardiologists in the utilization of bioresorbable scaffolds.

A. Low, H. Gwon, A. Seth, 2016, International journal of cardiology.

Optimum technique to reduce risk of stent thrombosis – Authors' reply

P. Serruys, G. Stone, Takeshi Kimura, 2016, The Lancet.

IMPACT OF FINAL MINIMAL STENT AREA BY IVUS ON 3-YEAR OUTCOME AFTER PCI OF LEFT MAIN CORONARY ARTERY DISEASE: THE EXCEL TRIAL

P. Serruys, G. Stone, F. Horkay, 2017 .

Early and late quantitative angiographic outcomes in the optimal atherectomy restenosis study (OARS)

M. Leon, D. Baim, G. Mintz, 1996 .

730-2 Acute Angiographic, Intravascular Ultrasound and Clinical Results of Directional Atherectomy in the Optimal Atherectomy Restenosis Study

P. Yock, R. Bersin, M. Leon, 1995 .

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease after

P. Serruys, G. Stone, D. Kandzari, 2017 .

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial.

P. Serruys, G. Stone, M. Leon, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention: Technique Analysis From the EXCEL Trial

P. Serruys, G. Stone, M. Leon, 2018, Circulation. Cardiovascular interventions.

Mobile cardiac catheterization registry: report of the first 1,001 patients.

R. Bersin, J. Gallagher, C. Simonton, 1994, Catheterization and cardiovascular diagnosis.

Clinical Outcomes Prior to and Following Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2019, Circulation.

Very Late Restenosis Following Bioresorbable Scaffold Implantation.

S. Saito, K. Tanabe, Takeshi Kimura, 2017, JACC. Cardiovascular interventions.

Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents.

R. Virmani, F. Otsuka, S. Yazdani, 2013, The Journal of invasive cardiology.

Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption

P. Teirstein, G. Stone, S. Ellis, 2019, Circulation.

Evaluation of the effects of everolimus‐eluting and paclitaxel‐eluting stents on target lesions with jailed side branches: 2‐year results from the SPIRIT III randomized trial

G. Stone, A. Lansky, J. Hermiller, 2010, Catheterization and cardiovascular interventions.

Can start-ups finish up?

C. Simonton, 2012, Circulation. Cardiovascular quality and outcomes.

Mobile cardiac catheterization: comparison with outpatient and inpatient catheterization at tertiary facilities.

R. Bersin, J. Gallagher, C. Simonton, 1994, Catheterization and cardiovascular diagnosis.

The safety and efficacy of the StarClose® vascular closure system: The ultrasound substudy of the CLIP study

M. Jaff, J. Hermiller, C. Simonton, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization.

C. O'shaughnessy, J. Hermiller, C. Simonton, 2005, The Journal of invasive cardiology.

Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.

K. Ellenbogen, M. Wood, C. Simonton, 1995, The American journal of cardiology.

Relationship between para-aminohippurate secretion and cellular morphology in rabbit proximal tubules.

R. R. Robinson, C. Simonton, P. B. Woodhall, 1978, The Journal of clinical investigation.

Preservation of regional myocardial function during coronary angioplasty with an autoperfusion balloon catheter: a case report.

C. Simonton, G. Kowalchuk, W. K. Austin, 1991, Catheterization and cardiovascular diagnosis.

Balloon angioplasty of the internal mammary artery trunk for early postoperative ischemia: a case report.

C. Simonton, J. Selle, A. Kollar, 1996, Catheterization and cardiovascular diagnosis.

Drug-eluting stents for emerging treatment strategies in complex lesions.

B. Brodie, C. Simonton, B. H. Wilson, 2005, Reviews in cardiovascular medicine.

Analytical ion cyclotron resonance spectrometry. Spectereochemical factors and a functional group interaction in some norbornyl systems

C. Simonton, M. M. Bursey, J. Kao, 1976 .

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2017, Journal of the American College of Cardiology.

Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.

R. Bersin, C. Simonton, H. Norton, 2004, JAMA.

2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy

P. Serruys, G. Stone, Z. Ali, 2017, The Lancet.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

P. Teirstein, G. Stone, S. Ellis, 2015, The New England journal of medicine.

Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?

P. Serruys, M. Banach, C. Simonton, 2016, International journal of cardiology.

Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study.

P. Fitzgerald, R. Bersin, M. Leon, 1998, Journal of the American College of Cardiology.

DES Overview: A Historical and Current Review of Pivotal Clinical Trial Programs

C. Simonton, P. Sood, K. Sudhir, 2012 .

Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.

E. B. Carlson, R. Califf, C. O'connor, 1988, Circulation.

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction.

E. B. Carlson, R. Califf, D. Pryor, 1988, Journal of the American College of Cardiology.

A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease

R. Califf, D. Mark, E. Topol, 1993 .

Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.

D. van Klaveren, E. Steyerberg, P. Serruys, 2015, European Heart Journal.

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.

P. Serruys, G. Stone, D. Kandzari, 2017, Journal of the American College of Cardiology.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease

P. Serruys, G. Stone, D. Kandzari, 2017 .

Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.

P. Teirstein, A. Yeung, P. Fitzgerald, 2000, Circulation.

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.

P. Teirstein, G. Stone, J. Moses, 2020, Journal of the American College of Cardiology.

Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.

Peter L Duffy, B. Brodie, T. Stuckey, 2009, JACC. Cardiovascular interventions.

Clinical and angiographic risk assessment in patients with left main stem lesions.

P. Serruys, G. Stone, S. Garg, 2010, JACC. Cardiovascular interventions.

Risk Factors for Coronary Drug-Eluting Stent Thrombosis: Influence of Procedural, Patient, Lesion, and Stent Related Factors and Dual Antiplatelet Therapy

J. Hermiller, C. Simonton, K. Sudhir, 2013, ISRN cardiology.

FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.

T. Feldman, J. Popma, C. Simonton, 2007, Journal of interventional cardiology.

Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study

P. Teirstein, A. Yeung, P. Fitzgerald, 2000 .

Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study.

M. Krucoff, S. Naidu, J. Hermiller, 2012, JACC. Cardiovascular interventions.

Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.

S. Pocock, P. Serruys, G. Stone, 2019, Journal of the American College of Cardiology.

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

Gregg W Stone, Alexandra J Lansky, G. Stone, 2010, The New England journal of medicine.

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

G. Stone, D. Kereiakes, D. Cutlip, 2010, Journal of the American College of Cardiology.

SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.

G. Stone, A. Lansky, D. Cutlip, 2009, American heart journal.

Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)

Y. Hayashi, T. Akasaka, K. Tanabe, 2012, Circulation.

Coronary and endovascular applications of the Absorb™ bioresorbable vascular scaffold

D. Scheinert, C. Simonton, L. Schwartz, 2012 .

Coronary and endovascular applications of the Absorb TM bioresorbable vascular scaffold CLINICAL TRIAL REPORT

D. Scheinert, C. Simonton, L. Schwartz, 2010 .

Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everol

P. Serruys, G. Stone, A. Lansky, 2011, JACC. Cardiovascular interventions.

Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel Meeting on the ACCULINK and ACCUNET Carotid Artery Stent System

W. Gray, C. Simonton, P. Verta, 2012, Circulation.

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial.

B. Gersh, S. Pocock, P. Serruys, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents.

C. Simonton, Santosh Prabhu, Tanya Schikorr, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.

Mitchell W. Krucoff, Vic Hasselblad, William Wijns, 2008, Journal of the American College of Cardiology.

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate

R. Bersin, C. Simonton, G. Kowalchuk, 2004 .

Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention among Medicare Beneficiaries.

I. Moussa, R. Yeh, J. Popma, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.

Peter L Duffy, B. Brodie, J. Hermiller, 2007, Journal of the American College of Cardiology.

Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.

Peter L Duffy, B. Brodie, T. Stuckey, 2008, JACC. Cardiovascular interventions.

An integer based risk score for predicting 30-day major adverse cardiac or cerebrovascular events after percutaneous coronary intervention with drug-eluting stents: results from a large prospective multicentre registry, the STENT Group.

Peter L Duffy, B. Brodie, J. Hermiller, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial.

Gregg W Stone, G. Stone, D. Kereiakes, 2011, Journal of the American College of Cardiology.

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials.

P. Serruys, G. Stone, M. Fahy, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study).

Mitchell W Krucoff, Weiying Zhao, Lalitha Jonnavithula, 2011, JACC. Cardiovascular interventions.

Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries

I. Moussa, R. Yeh, J. Popma, 2021, EuroIntervention.

An evidence‐based review of the impact of periprocedural myocardial infarction in carotid revascularization

W. Gray, C. Simonton, C. Mena-Hurtado, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical outcomes in real‐world patients with acute myocardial infarction receiving XIENCE V® everolimus‐eluting stents

T. Henry, S. Naidu, Jin Wang, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials

Bernard Chevalier, Yoshinobu Onuma, Takeshi Kimura, 2017, Circulation.

AngioJet experience from the multi-center STENT Registry.

B. Brodie, C. Simonton, M. Rinaldi, 2006, The Journal of invasive cardiology.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

S. Pocock, P. Serruys, G. Stone, 2016, The New England journal of medicine.

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2017, Journal of the American College of Cardiology.